Form 4: Tenaya Therapeutics Director Receives Stock Option Grant
Director Equity Grant
Director Amy L. Burroughs was granted 120,000 stock options in Tenaya Therapeutics, Inc. as part of the company's equity incentive plan.
Summary
- Director Amy L. Burroughs received a grant of 120,000 stock options on May 28, 2026.
- The options have an exercise price of $0.7989 per share.
- The options are scheduled to vest in full on May 28, 2027, or the day before the next annual stockholders meeting, whichever is earlier.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine corporate governance filing regarding director compensation with no immediate impact on company operations.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- Potential for future dilution of existing shareholders upon the exercise of these options.
Risks
- Vesting is contingent upon the director remaining a service provider to the issuer.
Future Outlook
The options vest in one year, signaling a commitment to the company's medium-term performance.
Industry Context
StockSavvy.ai notes that equity grants to non-employee directors are standard practice in the biotechnology sector to attract and retain board expertise.
Comparison to Industry Standards
- The grant size and vesting schedule are consistent with typical compensation packages for directors in small-cap biotech firms.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of 120,000 options under the 2021 Equity Incentive Plan. | 05/28/2026 | Standard director compensation alignment. |
Stakeholder Impact
- Shareholders may experience minor dilution if options are exercised.
Next Steps
- Vesting of options on May 28, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/28/2026 | Date of the stock option grant transaction. |
| 05/29/2026 | Date the Form 4 was filed with the SEC. |
| 05/28/2027 | Vesting date for the granted stock options. |
| 05/27/2036 | Expiration date of the stock options. |
Keywords
Tenaya Therapeutics, TNYA, Form 4, Stock Options, Director Compensation, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.